V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10477093 | 10036135 | 1.75 | 48.65 | null | null | 2022-02-24 | null | 02 | null | CARBOPLATIN + PACLITAXEL | 100597893 |
| 10477098 | 10036136 | 1.73 | 72.68 | Palliative (P) | null | 2016-05-04 | null | 02 | null | CARBOPLATIN + PACLITAXEL | 100277802 |
| 10477116 | 10036137 | null | null | Adjuvant (A) | 2015-04-21 | 2015-04-26 | CEMIPLIMAB | 02 | N | ABIRATERONE | 100984855 |
| 10477130 | 10036138 | 1.8 | 66.1 | null | null | 2017-10-27 | null | 02 | null | ABIRATERONE | 101268441 |
| 10477134 | 10036139 | 1.85 | 86.2 | Adjuvant (A) | null | 2016-11-20 | null | 02 | null | CARBOPLATIN + ETOPOSIDE | 100552561 |
| 10477162 | 10036140 | 1.8 | 71.8 | 03 | 2017-10-28 | 2017-11-06 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 100905170 |
| 10477172 | 10036141 | 1.66 | 70 | Curative (C) | 2016-10-14 | 2016-11-03 | RUXOLITINIB | 02 | null | RUXOLITINIB | 100606150 |
| 10477188 | 10036142 | 1.72 | 73.5 | Curative (C) | null | 2017-11-07 | null | 02 | N | LENALIDOMIDE | 100416347 |
| 10477190 | 10036143 | 1.6 | 85.7 | null | null | 2022-03-04 | null | 02 | null | BENDAMUSTINE + RITUXIMAB | 100765892 |
| 10477193 | 10036144 | 1.6 | 93.6 | null | 2016-11-17 | 2016-12-08 | BENDAMUSTINE + RITUXIMAB | null | null | BENDAMUSTINE + RITUXIMAB | 100741613 |
| 10477204 | 10036145 | 0 | null | Neo-adjuvant (N) | 2018-04-18 | 2018-04-24 | RUXOLITINIB | 02 | N | RUXOLITINIB | 100923057 |
| 10477242 | 10036146 | 1.69 | 81.6 | null | null | 2016-10-21 | null | null | null | CARBOPLATIN + PACLITAXEL | 101309209 |
| 10477258 | 10036147 | 1.6 | 77 | Adjuvant (A) | null | 2017-01-24 | null | 02 | null | CARBOPLATIN + PACLITAXEL | 100574424 |
| 10477262 | 10036148 | 1.73 | 82.7 | Adjuvant (A) | null | 2015-03-21 | null | null | N | BENDAMUSTINE + RITUXIMAB | 100944938 |
| 10477279 | 10036149 | 1.6 | 61.4 | Neo-adjuvant (N) | null | 2020-03-09 | null | 02 | N | CARBOPLATIN + PACLITAXEL | 100812204 |
| 10477283 | 10036150 | 0 | 86.3 | Palliative (P) | 2020-03-15 | 2020-03-30 | RUXOLITINIB | N | N | RUXOLITINIB | 101217169 |
| 10477284 | 10036151 | 1.7 | 80.6 | null | null | 2018-05-30 | null | null | null | ABIRATERONE | 100779797 |
| 10477285 | 10036152 | null | 52.4 | 03 | 2019-12-03 | 2019-12-03 | RUXOLITINIB | 02 | N | RUXOLITINIB | 101737016 |
| 10477319 | 10036153 | 1.57 | 58 | 03 | null | 2021-02-02 | null | 02 | N | CEMIPLIMAB | 101533098 |
| 10477334 | 10036154 | 1.74 | 59 | null | null | 2017-04-30 | null | 02 | N | BENDAMUSTINE + RITUXIMAB | 100421171 |
| 10477336 | 10036155 | 1.6 | 77.9 | Palliative (P) | 2016-11-21 | 2016-11-25 | Carboplatin + Etoposide iv&po | 02 | N | CARBOPLATIN + ETOPOSIDE | 101610542 |
| 10477366 | 10036156 | 1.73 | 60.9 | null | 2015-06-13 | 2015-06-13 | Bendamustine+Rituximab (1st Course) | 02 | null | BENDAMUSTINE + RITUXIMAB | 101165875 |
| 10477373 | 10036157 | 1.68 | 55.6 | null | null | 2021-05-20 | null | 02 | null | CARBOPLATIN + PACLITAXEL | 100163198 |
| 10477406 | 10036158 | 1.8 | 71 | Palliative (P) | null | 2021-09-19 | null | 02 | N | CEMIPLIMAB | 100486177 |
| 10477453 | 10036160 | 1.65 | 97.8 | Palliative (P) | null | 2018-09-28 | null | 02 | N | CARBOPLATIN + PACLITAXEL | 101485818 |
| 10477456 | 10036161 | 1.63 | 57 | Palliative (P) | 2021-01-21 | 2021-02-08 | CEMIPLIMAB | 02 | N | ABIRATERONE | 101226536 |
| 10477477 | 10036162 | 1.78 | 65.5 | null | 2017-08-03 | 2017-08-29 | BENDAMUSTINE + RITUXIMAB | null | null | BENDAMUSTINE + RITUXIMAB | 101609902 |
| 10477494 | 10036163 | null | null | 03 | null | 2018-01-09 | null | 02 | N | ABIRATERONE | 100376834 |
| 10477529 | 10036165 | 1.57 | 75 | Curative (C) | 2020-09-13 | 2020-09-21 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 100664761 |
| 10477557 | 10036166 | 1.69 | 86.1 | Palliative (P) | 2021-04-17 | 2021-04-17 | LENALIDOMIDE | 02 | null | LENALIDOMIDE | 100599747 |
| 10477580 | 10036167 | 1.82 | 68.7 | 03 | 2020-02-19 | 2020-02-27 | Abiraterone | 02 | N | ABIRATERONE | 101762335 |
| 10477618 | 10036168 | 1.76 | 69.8 | Palliative (P) | 2016-12-25 | 2018-01-12 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100593715 |
| 10477634 | 10036169 | 1.7 | 78 | Disease modification (D) | 2018-11-30 | 2018-11-30 | LENALIDOMIDE | 02 | N | LENALIDOMIDE | 101348674 |
| 10477638 | 10036170 | 0 | 94.9 | null | 2017-07-01 | 2017-07-27 | RUXOLITINIB | 02 | N | RUXOLITINIB | 100929173 |
| 10477650 | 10036171 | null | 74.8 | null | 2018-02-09 | 2018-02-11 | RUXOLITINIB | 02 | null | RUXOLITINIB | 101047701 |
| 10477703 | 10036172 | 1.74 | null | Curative (C) | null | 2016-11-12 | CARBOPLATIN + ETOPOSIDE | 99 | null | CARBOPLATIN + ETOPOSIDE | 100037757 |
| 10477711 | 10036173 | 1.53 | 78 | null | 2018-03-03 | 2018-03-19 | CARBOPLATIN + PACLITAXEL | null | null | CARBOPLATIN + PACLITAXEL | 101433017 |
| 10477716 | 10036174 | 1.62 | 72.2 | Curative (C) | 2019-12-18 | 2019-12-21 | CARBOPLATIN + ETOPOSIDE | 02 | null | CARBOPLATIN + ETOPOSIDE | 100744934 |
| 10477732 | 10036175 | 1.57 | 59 | Palliative (P) | 2018-11-02 | 2018-11-09 | Carboplatin + Etoposide iv&po | 02 | null | CARBOPLATIN + ETOPOSIDE | 101236872 |
| 10477733 | 10036176 | 1.59 | 68.8 | null | 2019-03-23 | 2019-03-30 | CARBOPLATIN | null | null | CARBOPLATIN | 100018737 |
| 10477747 | 10036177 | 1.75 | 0 | Palliative (P) | 2018-07-03 | 2018-07-15 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 100255718 |
| 10477780 | 10036178 | 1.63 | 63.9 | 02 | null | 2017-12-18 | null | 02 | N | RUXOLITINIB | 101618022 |
| 10477781 | 10036179 | 1.84 | 61.7 | null | 2022-02-28 | 2022-02-28 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100106095 |
| 10477803 | 10036180 | 1.58 | 68.4 | Palliative (P) | 2018-02-18 | 2018-02-18 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL | 101715089 |
| 10477805 | 10036181 | 1.82 | 88.45 | Adjuvant (A) | 2017-06-06 | 2017-06-07 | RUXOLITINIB | 02 | N | RUXOLITINIB | 101618859 |
| 10477816 | 10036182 | 1.71 | 63.1 | Palliative (P) | null | 2017-11-29 | null | 02 | null | CARBOPLATIN + PACLITAXEL | 101517767 |
| 10477823 | 10036183 | 1.8 | 61.6 | Neo-adjuvant (N) | 2022-05-05 | 2022-05-12 | LENALIDOMIDE | 02 | N | LENALIDOMIDE | 100858400 |
| 10477829 | 10036184 | 1.67 | 72.1 | Palliative (P) | 2017-03-01 | 2017-03-09 | CARBOPLATIN + ETOPOSIDE | 02 | N | CARBOPLATIN + ETOPOSIDE | 100160590 |
| 10477830 | 10036185 | 1.52 | 54 | 03 | 2016-04-13 | 2019-03-19 | LENALIDOMIDE | 02 | N | LENALIDOMIDE | 100663810 |
| 10477847 | 10036186 | 1.75 | 55.6 | null | 2017-12-20 | 2018-01-02 | CARBOPLATIN + ETOPOSIDE | null | null | CARBOPLATIN + ETOPOSIDE | 100194670 |